Li Fu
8Patents
8Active
8Granted
42Portfolio score
Filing activity: Jul 12, 2013 → Feb 21, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9333215B2 | Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10238676B2 | Application of ginsenoside RG3 in preparing medicine for preventing and/or treating dementia, and medicine for treating dementia | Human Necessities | 0 | Active |
| US10286002B2 | Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases | Human Necessities | 0 | Active |
| US10881679B2 | Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases | Human Necessities | 0 | Active |
| US9670224B2 | Forsythiaside sulfate and derivatives thereof, preparation method and application thereof | Human Necessities | 0 | Active |
| US10675317B2 | Use of ginseng extract, ginsenoside and ginsenoside derivative in the preparation of medicine or health care product for treating cytomegalovirus infection disorders | Human Necessities | 0 | Active |
| US9969766B2 | 20(R)-ginsenoside Rg3 polyacylated derivatives, preparation and application thereof | Chemistry; Metallurgy | 0 | Active |
| US10407455B2 | Phillygenin glucuronic acid derivative as well as preparation method and application thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.